These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 4561348)

  • 1. Changes in staff anxiety and attitudes during a double blind study of haloperidol in acute schizophrenics within a structured milieu.
    Singh MM; Di Scipio WJ
    J Nerv Ment Dis; 1972 Oct; 155(4):245-56. PubMed ID: 4561348
    [No Abstract]   [Full Text] [Related]  

  • 2. Sleeplessness in acute and chronic schizophrenia--response to haloperidol and anti-parkinsonism agents.
    Singh MM; Smith JM
    Psychopharmacologia; 1973 Feb; 29(1):21-32. PubMed ID: 4571938
    [No Abstract]   [Full Text] [Related]  

  • 3. Psychopharmacological study of schizophrenia--some ways out of an impasse. A case study with haloperidol.
    Singh MM
    Int Pharmacopsychiatry; 1973; 8(1):80-98. PubMed ID: 4595193
    [No Abstract]   [Full Text] [Related]  

  • 4. A quantitative study of neuroleptic-induced extrapyramidal symptoms and their response to dexetimide, a potent and long-acting antiparkinsonian agent.
    Dom R; Van Lommel R; Baro F
    Acta Psychiatr Scand; 1971; 47(4):399-410. PubMed ID: 4947805
    [No Abstract]   [Full Text] [Related]  

  • 5. Evaluating the long-term need for antiparkinson drugs by chronic schizophrenics.
    Klett CJ; Caffey E
    Arch Gen Psychiatry; 1972 Apr; 26(4):374-9. PubMed ID: 4552131
    [No Abstract]   [Full Text] [Related]  

  • 6. Atypical tardive dyskinesia.
    Moline RA
    Am J Psychiatry; 1975 May; 132(5):534-5. PubMed ID: 1119614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparative study of haloperidol and chlorpromazine in terms of clinical effects and therapeutic reversal with benztropine in schizophrenia. Theoretical implications for potency differences among neuroleptics.
    Singh MM; Kay SR
    Psychopharmacologia; 1975 Aug; 43(2):103-13. PubMed ID: 1103205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Higher than usual dosage of haloperidol: a pilot study in 'back ward' schizophrenics.
    Tanghe A; Declercq H
    Proc R Soc Med; 1976; 69 suppl 1(Suppl 1):50-3. PubMed ID: 798191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversal of some therapeutic effects of an antipsychotic agent by an antiparkinsonism drug.
    Singh MM; Smith JM
    J Nerv Ment Dis; 1973 Jul; 157(1):50-8. PubMed ID: 4713306
    [No Abstract]   [Full Text] [Related]  

  • 10. Benztropine prophylaxis of dystonic reactions.
    Stern TA; Anderson WH
    Psychopharmacology (Berl); 1979 Mar; 61(3):261-2. PubMed ID: 36644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A controlled comparison of haloperidol and fluphenazine in chronic treatment-resistant schizophrenics.
    Hall WB; Vestre ND; Schiele BC; Zimmermann R
    Dis Nerv Syst; 1968 Jun; 29(6):405-8. PubMed ID: 4877748
    [No Abstract]   [Full Text] [Related]  

  • 12. A double-blind study of amantadine hydrochloride versus benztropine mesylate in drug-induced parkinsonism.
    Kelly JT; Zimmermann RL; Abuzzahab FS; Schiele BC
    Pharmacology; 1974; 12(2):65-73. PubMed ID: 4610599
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of two butyrophenone compounds on acute schizophrenic patients: speculation on the neurophysiologic sites of action.
    Gallant DM; Bishop M; Guerrero-Figueroa R
    Int J Neuropsychiatry; 1967 Aug; 3():Suppl 1:53-60. PubMed ID: 4860981
    [No Abstract]   [Full Text] [Related]  

  • 14. Double-blind comparison of risperidone and haloperidol in schizophrenic and schizoaffective psychoses.
    Cesková E; Svestka J
    Pharmacopsychiatry; 1993 Jul; 26(4):121-4. PubMed ID: 7694306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loxapine succinate: a double-blind comparison with haloperidol and placebo in acute schizophrenics.
    Selman FB; McClure RF; Helwig H
    Curr Ther Res Clin Exp; 1976 Jun; 19(6):645-52. PubMed ID: 819222
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical observations of the treatment of tardive dyskinesia with haloperidol.
    Frangos E; Christodoulides H
    Acta Psychiatr Belg; 1975 Jan; 75(1):19-32. PubMed ID: 785948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Olanzapine vs haloperidol for treatment of schizophrenia.
    Glazer WM
    JAMA; 2004 Mar; 291(9):1064-5; author reply 1065-6. PubMed ID: 14996766
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment of phenothiazine drug intoxication with benztropine.
    Bellman MH
    Arch Dis Child; 1974 Aug; 49(8):664-5. PubMed ID: 4424791
    [No Abstract]   [Full Text] [Related]  

  • 19. New dystonic syndrome associated with butyrophenone therapy.
    Ekbom K; Lindholm H; Ljungberg L
    Z Neurol; 1972; 202(2):94-103. PubMed ID: 4115928
    [No Abstract]   [Full Text] [Related]  

  • 20. Therapeutic reversal with benxtropine in schizophrenics. Practical and theoretical significance.
    Singh MM; Kay SR
    J Nerv Ment Dis; 1975 Apr; 160(4):258-66. PubMed ID: 1097596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.